Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Margin of Safety % (DCF Earnings Based): N/A (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02252 Shanghai MicroPort MedBot (Group) Co Ltd HKSE:02252
45 GF Score
Price HK$25.48
GF Value HK$81.81
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Shanghai MicroPort MedBot (Group) Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shanghai MicroPort MedBot (Group) Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

HKSE:02252 vs ABT, SYK, MDT: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai MicroPort MedBot (Group) Co Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's Margin of Safety % (DCF Earnings Based) falls into.


HKSE:02252
45GF Score
Shanghai MicroPort MedBot (Group) Co Ltd HKSE:02252
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co stock appears to be undervalued. The current stock price of HK$25.48 is trading 68.9% below its estimated GF Value™ of HK$81.81. GuruFocus considers Shanghai MicroPort MedBot (Group) Co to be Possible Value Trap.

Key valuation signals for HKSE:02252:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: HK$81.81 vs. price of HK$25.48 (68.9% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the HKSE:02252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai MicroPort MedBot (Group) Co Business Description

Address 1601 Zhangdong Road, Room 101, Area B, Building 1, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The business of the company covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives maximum revenue from the People's Republic of China.
45GF Score

Get the complete analysis for HKSE:02252

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$25.48
Price
HK$81.81
GF Value